Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Photoreceptors and Visual Pathways

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

In-Hospital Mortality in Hemorrhagic Myocardial Infarction.

NEJM evidence·2025

Same author

Serum pro-brain natriuretic peptide correlates with optical coherence tomography indices in diabetic retinopathy.

Molecular vision·2025

Same author

Serum pro-brain natriuretic peptide correlates with optical coherence tomography indices in diabetic retinopathy.

Molecular vision·2025

Same author

The Ellipsoid Zone Is a Structural Biomarker for Visual Outcomes in Diabetic Macular Edema and Macular Hole Management.

Vision (Basel, Switzerland)·2025

Same author

Myopia Support Device (Titanium Macular Buckle) for Posterior Pole Retinal Detachment With or Without Myopic Maculoschisis.

Journal of vitreoretinal diseases·2024

Same author

Retinal photoreceptor ellipsoid zone is a structural biomarker for visual outcome after successful macular hole surgery: A novel grading system-based study.

Indian journal of ophthalmology·2024

Search research articles

Related Experiment Video

Updated: May 9, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Ocular vasculitis.

Gabriela M Espinoza¹, Ankit Desai, Levent Akduman

¹Department of Ophthalmology, Saint Louis University School of Medicine, Saint Louis University Eye Institute, 1755 South Grand Blvd, St. Louis, MO 63104, USA. gespinoz@slu.edu

Current Rheumatology Reports

|July 27, 2013

Summary

This summary is machine-generated.

Ocular vasculitis, blood vessel inflammation in the eye, can cause vision loss and indicate serious systemic diseases. Early diagnosis and collaboration between ophthalmologists and rheumatologists are crucial for effective treatment.

More Related Videos

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Related Experiment Videos

Last Updated: May 9, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Area of Science:

Ophthalmology
Rheumatology
Immunology

Background:

Vasculitis involves blood vessel inflammation, potentially causing tissue damage like ischemia and necrosis.
Ocular vasculitis presents with visible symptoms and can severely impact vision and quality of life.
Ophthalmic manifestations can be the initial sign of systemic, life-threatening vasculitic diseases.

Purpose of the Study:

To highlight the significance of ocular vasculitis as a potential indicator of systemic disease.
To emphasize the importance of interdisciplinary collaboration in managing vasculitis patients.

Main Methods:

Review of systemic vasculitides associated with ocular manifestations.
Discussion of diagnostic and treatment strategies for ocular vasculitis.

Main Results:

Systemic vasculitides frequently manifest in the eye.
Conditions like ANCA-associated vasculitis, Behcet's disease, rheumatoid arthritis, sarcoidosis, and lupus erythematosus are linked to ocular vasculitis.
Ocular symptoms can precede the diagnosis of systemic disease.

Conclusions:

Ocular vasculitis requires prompt recognition due to its potential to signal severe systemic illness.
Effective management necessitates close collaboration between ophthalmologists and rheumatologists to ensure accurate diagnosis and treatment.